Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

Clinical trial NCT04519151 · RECRUITING

Trial details

NCT number: NCT04519151
Sponsor: Sheba Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Carcinoma, Ovarian Epithelial Neoplasm of Stomach Ovarian Diseases Genital Neoplasms, Female Ovarian Epithelial Tumor Urogenital Neoplasms Neoplasms, Glandular and Epithelial

Start date: 2021-04-12
Primary completion: 2023-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.